Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominic Edelmann

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Gut|November 5, 2017
Genome-wide DNA methylation analysis reveals a prognostic classifier for non-metastatic colorectal cancer (ProMCol classifier)Melanie Gündert, Dominic Edelmann, Axel Benner, et al.
Ebiomedicine|June 25, 2024
Large-scale external validation and meta-analysis of gene methylation biomarkers in tumor tissue for colorectal cancer prognosisTanwei Yuan, Durgesh Wankhede, Dominic Edelmann, et al.
Cell Reports|June 14, 2018
Cell-of-Origin DNA Methylation Signatures Are Maintained during Colorectal CarcinogenesisFelix Bormann, Manuel Rodríguez-Paredes, Felix Lasitschka, et al.
Critical Reviews in Oncology/Hematology|November 12, 2023
CpG-biomarkers in tumor tissue and prediction models for the survival of colorectal cancer: A systematic review and external validation studyTanwei Yuan, Dominic Edelmann, Jakob N Kather, et al.
Epigenomics|November 23, 2019
DNA methylation profiling to explore colorectal tumor differences according to menopausal hormone therapy use in womenSonja Neumeyer, Odilia Popanda, Katja Butterbach, et al.
Plos One|September 22, 2017
Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic diseaseNina Wagener, Dominic Edelmann, Axel Benner, et al.
Epigenetics|April 2, 2019
Genome-wide DNA methylation differences according to oestrogen receptor beta status in colorectal cancerSonja Neumeyer, Odilia Popanda, Dominic Edelmann, et al.
Clinical Epigenetics|July 26, 2019
A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survivalMin Jia, Yan Zhang, Lina Jansen, et al.
Translational Oncology|May 1, 2025
Identification and external validation of tumor DNA methylation panel for the recurrence risk stratification of stage II colon cancerTanwei Yuan, Dominic Edelmann, Víctor Moreno, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 19, 2022
Predictive Polygenic Score for Outcome after First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients Using Supervised Principal Component AnalysisHanla A Park, Dominic Edelmann, Federico Canzian, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Gut|November 5, 2017
Genome-wide DNA methylation analysis reveals a prognostic classifier for non-metastatic colorectal cancer (ProMCol classifier)Melanie Gündert, Dominic Edelmann, Axel Benner, et al.
Ebiomedicine|June 25, 2024
Large-scale external validation and meta-analysis of gene methylation biomarkers in tumor tissue for colorectal cancer prognosisTanwei Yuan, Durgesh Wankhede, Dominic Edelmann, et al.
Cell Reports|June 14, 2018
Cell-of-Origin DNA Methylation Signatures Are Maintained during Colorectal CarcinogenesisFelix Bormann, Manuel Rodríguez-Paredes, Felix Lasitschka, et al.
Critical Reviews in Oncology/Hematology|November 12, 2023
CpG-biomarkers in tumor tissue and prediction models for the survival of colorectal cancer: A systematic review and external validation studyTanwei Yuan, Dominic Edelmann, Jakob N Kather, et al.
Epigenomics|November 23, 2019
DNA methylation profiling to explore colorectal tumor differences according to menopausal hormone therapy use in womenSonja Neumeyer, Odilia Popanda, Katja Butterbach, et al.
Plos One|September 22, 2017
Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic diseaseNina Wagener, Dominic Edelmann, Axel Benner, et al.
Epigenetics|April 2, 2019
Genome-wide DNA methylation differences according to oestrogen receptor beta status in colorectal cancerSonja Neumeyer, Odilia Popanda, Dominic Edelmann, et al.
Clinical Epigenetics|July 26, 2019
A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survivalMin Jia, Yan Zhang, Lina Jansen, et al.
Translational Oncology|May 1, 2025
Identification and external validation of tumor DNA methylation panel for the recurrence risk stratification of stage II colon cancerTanwei Yuan, Dominic Edelmann, Víctor Moreno, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 19, 2022
Predictive Polygenic Score for Outcome after First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients Using Supervised Principal Component AnalysisHanla A Park, Dominic Edelmann, Federico Canzian, et al.
Pageof 5